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Background/Aims: Gastroesophageal reflux (GER) has 
been implicated in the pathogenesis of chronic cough. The 
aims of this study were to evaluate the diagnostic usefulness 
of multichannel intraluminal impedance combined with pH 
monitoring (MII/pH monitoring) in patients with suspected 
symptoms of gastroesophageal reflux disease (GERD) and 
to assess the correlation between GER symptoms and reﬂ  ux 
nature. Methods: Seventy patients with suspected symp-
toms of GERD (such as heartburn, acid regurgitation, non-
cardiac chest pain, globus and chronic cough) were enrolled. 
All patients were asked to discontinue medications that 
would inﬂ  uence esophageal motor function and gastric acid 
secretion at least one week ago. All subjects underwent 
MII/pH monitoring. Results: Forty-five patients (64.3%) 
were diagnosed with GERD. Among these patients, eleven 
patients (15.7%) had pathologic acid reﬂ  ux by pH data and 
thirty-four patients (48.6%) had pathologic bolus exposure 
by impedance. Subjects with chronic cough had a higher De-
Meester score (p=0.009), percentage of acid exposure time 
(p=0.007), acid bolus exposure % time (p=0.027), distal acid 
reﬂ  ux episodes (p=0.015) and proximal acid reﬂ  ux episodes 
(p=0.030) than subjects without chronic cough. Conclu-
sions: The results of this study showed that the impedance 
monitoring enhanced diagnostic sensitivity than pH-monitor-
ing alone by 48.6%. In addition, reﬂ  ux episodes at the distal 
and proximal esophagus were noted to be important factors 
associated with chronic cough. (Gut Liver 2012;6:197-202)
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INTRODUCTION
Gastroesophageal reflux disease (GERD) has a high prevalence 
and an increasing incidence. In Western societies, 10% to 20% 
of the adult population have symptoms of GERD.
1,2 Although 
the frequency of GERD is lower,
3,4 the prevalence of GERD is 
recently is increasing in Asian countries including Korea.
5 Apart 
from the typical symptoms such as heartburn and acid regurgi-
tation, and the atypical or extraesophageal symptoms such as 
chronic cough, globus sensation in the throat and hoarseness 
are thought to be caused by pathological reflux of gastric con-
tent into the esophagus.
6
The significance of the diagnosis and the treatment of atypi-
cal manifestations of GERD is still a matter of debate. The as-
sessment of response to empirical treatment with proton pump 
inhibitors (PPIs) is often the first option of diagnosis. However, 
patients with atypical gastroesophageal reflux (GER) symptoms 
usually have a lower response to double dose PPI therapy.
7,8
Traditionally, 24-hour ambulatory pH monitoring has been 
recognized as a standard diagnostic test for GERD. Currently, 
multichannel intraluminal impedance combined with pH moni-
toring (MII/pH-monitoring) is considered as the most sensitive 
tool for the diagnosis and characterization of GERD.
9-11 This 
procedure is used to determine the quantity and quality of 
weakly alkaline and weakly acidic reflux episodes, apart from 
acidic reflux events, by the exact determination of the exposure 
time and the proximal extent of the refluxates.
10
The aims of this study were to evaluate the diagnostic useful-
ness of MII/pH-monitoring in patients with suspected symptoms 
of GERD and to assess the correlation between GERD symptoms 
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MATERIALS AND METHODS
1. Subjects
We performed a prospective study of 70 patients with sus-
pected GERD symptoms who referred to Chonnam National 
University Hospital between March 2009 and March 2011. 
The exclusion criteria were subjects with a history of thoracic, 
esophageal, or gastric surgery; those with primary and/or sec-
ondary severe esophageal motility disorders (e.g., achalasia, 
scleroderma, autonomic or peripheral neuropathy and myopa-
thy); pregnant women; and those with a history of alcohol or 
drug abuse. Patients were asked to discontinue any medication 
that would influence esophageal motor function and gastric acid 
excretion (such as H2 receptor antagonists, PPIs) at least one 
week before the MII/pH monitoring. The typical GERD symp-
toms included heartburn and acid regurgitation; atypical GERD 
symptoms included non-cardiac chest pain (NCCP), globus and 
chronic cough. Subjects with a chronic cough, not associated 
with asthma, had a cough lasting longer than 8 weeks, normal 
spirometry, and a negative methacholine challenge test. The 
subjects were asked to complete the questionnaires consisted 
of questions about the patient’s symptoms. The questionnaires 
included severities, durations and frequencies of reflux related 
symptoms (heart burn, acid regurgitation, chest pain, hoarse-
ness, globus sensation and cough). The severities of reflux re-
lated symptoms were recorded by 10 cm visual analogue scales 
running from 0 (no symptom) to 10 (maximal symptom ex-
pression). This study was approved by the Institutional Review 
Board at Chonnam National University Hospital. All patients 
provided written informed consent. 
2. Esophageal impedance/pH-monitoring
1) MII/pH-monitoring
The MII/pH probe consists of a 2.3 mm polyurethane cath-
eter incorporating six impedance segments (each segment 2 cm 
long) and one pH-measuring electrode (Sandhill Scientific Inc., 
Denver, CO, USA). The configuration of this catheter allowed 
the recording of changes in the intraluminal impedance at 3, 5, 
7, 9, 15, and 17 cm above the lower esophageal sphincter (LES). 
In addition, the pH was monitored at 5 cm above the LES. After 
defining the LES by using conventional manometry. The MII/
pH probe was inserted transnasally and the distal pH probe was 
positioned 5 cm above the LES. Data from the impedance chan-
nels and the pH electrodes were transmitted at frequency of 
50 Hz and stored on a portable data recorder (Sleuth; Sandhill 
Scientific Inc., Highlands Ranch, CO, USA). After 24-hours of 
recording, data was uploaded onto a personal computer and an-
alyzed by using commercially available software system (Bioview 
Analysis; Sandhill Scientific Inc., Highlands Ranch, CO, USA). 
During the recording period, patients were encouraged to par-
ticipate in regular activities and have routine meals: they were 
given a personal diary to note meal times, time in the recum-
bent position, and the timing of any GERD-related symptoms.
2) pH data analysis
Acid reflux episodes were defined as a drop in pH to less than 
4 for at least 5 seconds. The acid exposure percent time was 
calculated as the total time of the acid reflux episodes divided 
by the monitoring time. The DeMeester score, widely used to 
evaluate acid reflux, was obtained using 6 different parameters: 
1) total percent of time when the pH was <4.0, 2) percent time 
when the pH was <4.0 during the upright period, 3) percent 
time when pH was <4.0 during the recumbent period, 4) the 
total number of acid reflux episodes, 5) the total number of acid 
reflux episodes longer than 5 minutes, and 6) the duration of 
the longest acid reflux episodes.
12
3) Analysis of MII data
The meal periods were excluded from the analysis. These re-
flux episodes were classified as acidic if the pH dropped below 4 
or as non-acidic if the pH remained above 4 during the episode. 
A proximal reflux event was considered when the refluxate 
reached 15 cm of the impedance sensor. The acid exposure per-
cent time was calculated as the total time of acid reflux episodes 
Table 1. Patient Characteristics 
Characteristic Total (n=70)
Age, yr 54.8±13.9






  Mucosal break of Z-line (-) 55/58 (94.8)
  Mucosal break of Z-line (+) 3/58 (5.2)
GERD by pH data 11 (15.7)
GERD by MII data* 45 (64.3)
Typical symptoms 43 (61.4)
  Heartburn 29 (41.4)
  Acid regurgitation 30 (42.9)
Atypical symptoms
† 63 (90.0)
  NCCP 31 (44.3)
  Globus 36 (51.4)
  Cough 30 (42.9)
Underlying disease
  CAD 5 (7.1)
Data are presented as mean±SD or number (%).
BMI, body mass index; EGD, esophagogastroduodenoscopy; GERD, 
gastroesophageal reflux disease; NCCP, non-cardiac chest pain; CAD, 
coronary arterial disease.
*The patients who were diagnosed as GERD by impedance (pathologic 
bolus exposure); 
†Among the 63 patients, 36 patients had both typical 
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divided by the monitoring time. The bolus exposure percent 
time was defined as the sum of the bolus clearance time, of all 
individual reflux episodes, divided by the monitoring time. The 
bolus clearance time was defined as the time from a drop in 
impedance to 50% of the baseline value to recovery of 50% of 
the baseline value at the most distal impedance channel. The 
MII/pH monitoring data was analyzed except for reflux epi-
sodes that were followed by cough (cough-reflux sequence). The 
acid exposure percent time of the distal pH probe >4.0% or a 
DeMeester score >14.7 was defined as acid GERD. The bolus ex-
posure percent time of more than 1.4% without acid GERD was 
diagnosed as nonacid GERD.
3. Statistical methods
All continuous variables are presented as the median (range) 
or mean±SD and the proportions expressed as numbers (%). The 
independent sample t-test, Mann-Whitney U test and chi-square 
test were used for data analysis. The computer software used for 
statistical analysis was IBM SPSS version 18.0 (IBM, New York, 
NY, USA). A p-value of <0.05 was considered statistically sig-
nificant.
RESULTS
Table 1 summarizes the characteristics of the enrolled sub-
jects. Mean age of subjects was 54.8±13.9 years. There were 35 
males (50.0%) and the mean body mass index was 23.9±3.4 kg/
m
2. There were 43 subjects (61.4%) with typical GER symptoms 
such as heartburn or acid regurgitation. Sixty-three subjects 
(90.0%) had atypical GER symptoms such as NCCP, globus and 
a chronic cough. And thirty-six subjects (51.4%) had both typi-
cal & atypical symptoms. The examination was well tolerated 
by all subjects. 
1. Results of MII/pH-monitoring
1) Result of pH data 
Eleven out of 70 (15.7%) subjects had diagnosed as patholog-
ic acid reflux because their percent time pH <4.0 was over 4.0% 
or DeMeester score was over 14.7 point. 
2) Result of MII data 
Among 59 subjects that had negative result by pH data, 34 
subjects had the result that total bolus reflux percent time was 
over 1.4%. These subjects were additionally diagnosed with 
nonacid GERD (Fig. 1). 
2. Clinical characteristics and MII/pH values in subjects 
with each GER symptoms
Table 2 shows the clinical characteristics and MII/pH values 
of subjects with typical GER symptoms and without typical GER 
symptoms. There was no significant difference in the results of 
MII/pH values between subjects with typical GER symptoms 
and subjects without typical GER symptoms. There was no sig-
nificant difference in the results of the MII/pH values between 
subjects with NCCP and subjects without NCCP. In addition, 
there was no significant difference in the results of the MII/
pH between patients with globus and patients without globus. 
However, the subjects with chronic cough had higher DeMeester 
score, acid exposure percent time, acid bolus exposure percent 
time, distal acid reflux episodes and proximal acid reflux epi-
sodes than patients without chronic cough (p<0.05) (Table 3). 
DISCUSSION
The combined MII/pH-monitoring is considered as the most 
sensitive tool for assessing all types of GER (acidic, weakly 
acidic and weakly alkaline), their composition, proximal extent, 
duration and clearing.
11,13 In this study, 45 patients (64.3%) of 
the enrolled subjects were diagnosed as GERD by MII/pH-moni-
toring. Thirty-four patients of them would have been interpreted 
as having negative findings if tested only by means of conven-
tional pH monitoring. These findings showed the diagnostic 
usefulness of MII/pH-monitoring in the patients with suspected 
GERD.
The diagnosis of reflux in patients with atypical symptoms 
and the establishment of a clear relationship between reflux 
Fig. 1. Diagnostic usefulness of MII/
pH-monitoring. Forty-five patients 
(64.3%) are diagnosed with gastro-
esophageal reflux disease (GERD). 
Among these patients, 11 patients 
(15.7%) have acid reflux and 34 pa-
tients (48.6%) had non-acid reflux.200  Gut and Liver, Vol. 6, No. 2, April 2012
Table 2. Comparison of Clinical Characteristics and Impedance Data between the Patients with Typical Gastroesophageal Reflux (GER) Symptoms 
and Patients without Typical GER Symptoms
Characteristic Patients with typical symptoms (n=43) Patients without typical symptoms (n=27) p-value
Age, yr  55.0±14.0  54.5±14.0 0.886
Male  21 (48.8)  14 (51.9) 0.806
BMI, kg/m
2 23.6±3.6 24.4±3.2 0.401
Smoking   5 (11.6)  2 (7.4) 0.567
Alcohol  10 (23.3)   6 (22.2) 0.920
GERD by pH data   7 (16.3)   4 (14.8) 0.870
GERD by MII data*  26 (60.5)  19 (70.4) 0.400
Acid exposure, % time  2.41 (0-36.3)  1.77 (0-13.7) 0.966
DeMeester score     8.22 (0.8-113.7)   6.53 (0.8-46.6) 0.836
Bolus exposure, % time    2.52 (0.3-16.1)   2.81 (0.1-13.9) 0.259
  Acid  1.30 (0-13.4)  1.19 (0-12.3) 0.310
  Nonacid 1.21 (0-3.7)   1.63 (0.1-6.3) 0.266
Total number of reflux events   66.3 (13-219)  63.8 (2-147) 0.507
  Acid  24.3 (0-137) 22.2 (0-80) 0.809
  Nonacid   42.0 (11-170)  41.5 (2-101) 0.616
Number of proximal reflux events 27.2 (4-77) 27.5 (1-71) 0.828
  Acid 12.1 (0-67) 11.0 (0-53) 0.781
  Nonacid 15.1 (1-49) 16.6 (1-59) 0.933
Data are presented as mean±SD or number (%).
BMI, body mass index; GERD, gastroesophageal reflux disease.
*GERD by MII data, the patients who were diagnosed as GERD by impedance (pathologic bolus exposure).
Table 3. Comparison of Clinical Characteristics and Impedance Data between the Patients with Chronic Cough and Patients without Chronic Cough
Characteristic Patients with a cough (n=30)  Patients without a cough (n=40)  p-value
Age, yr  50.1±14.1  58.3±13.0 0.013
Male  12 (40.0)   22 (55.0) 0.147
BMI, kg/m
2 24.3±4.0 23.5±2.8 0.435
Smoking   3 (10.0)    4 (10.0) 1.000
Alcohol   7 (23.3)    9 (22.5) 0.935
GERD by pH data   6 (20.0)    5 (12.5) 0.394
GERD by MII data*  21 (70.0)   24 (60.0) 0.388
Acid exposure, % time  2.53 (0-13.7)    1.89 (0-36.3) 0.007
DeMeester score    8.78 (0.8-46.6)      6.66 (0.8-113.7) 0.009
Bolus exposure, % time    2.97 (0.4-13.9)     2.37 (0.1-16.1) 0.091
  Acid  1.69 (0-12.3)    0.93 (0-13.4) 0.027
  Nonacid   1.30 (0.1-3.6) 1.43 (0-6.3) 0.695
All distal reflux episodes   76.9 (17-219)    56.6 (2-151) 0.077
  Acid  34.0 (0-137) 15.6 (0-71) 0.015
  Nonacid   42.9 (13-170)  41.0 (2-101) 0.735
All proximal reflux episodes 31.4 (7-77)   24.3 (1-60) 0.161
  Acid 16.9 (0-67)    7.8 (0-32) 0.030
  Nonacid 14.5 (1-35)   16.5 (1-59) 0.868
Data are presented as mean±SD or number (%).  
BMI, body mass index; GERD, gastroesophageal reflux disease.
*GERD by MII data, the patients who were diagnosed as GERD by impedance (pathologic bolus exposure).Lee JH, et al: Reflux Episode Reaching the Proximal Esophagus Are Associated with Chronic Cough  201
and atypical GER symptoms can be challenging. Bajbouj et 
al.
14 reported that 63.4% of ‘off-PPI’ patients with atypical GER 
symptoms had pathological GER and 61% of patients were 
diagnosed with GERD by MII/pH-monitoring. Mallhotra et 
al.
15 evaluated patients with suspected extraesophageal GERD 
who were on or off PPI therapy, and concluded that MII/pH-
monitoring was useful for ruling out GERD and redirecting 
the management of patients. Unlike typical GER symptoms, 
which often respond well to conventional doses of PPI therapy, 
atypical GER symptoms require longer periods of therapy and/
or higher doses. However, despite the aggressive antisecretory 
regimens the symptoms often responded poorly. Some studies 
with MII/pH-monitoring have demonstrated that nonacid reflux 
persists during PPI therapy.
16 Weak acid reflux (pH 4 to 7) may 
induce symptoms of GERD such as heartburn, regurgitation, 
and noncardiac chest pain. In the present study, the subjects 
with chronic cough had more acid reflux episodes at the distal 
esophagus than subjects without chronic cough. In addition, the 
results of this study showed that the frequency of acid reflux 
episodes at the proximal esophagus was significantly higher 
in the subjects with chronic cough compared to the subjects 
without chronic cough. Acid reflux is thought to be a common 
cause of chronic cough, and esophageal instillation of acidic so-
lutions may increase symptoms in selected patients with chronic 
cough and abnormal pH-monitoring.
17 A recent study in GERD-
confirmed patients demonstrated that whilst infusion of acid 
(compared to saline) into the esophagus of those without cough 
had no effect, the cough reflex becomes significantly sensitized 
to capsaicin in those with chronic cough.
18 However, the results 
of this study showed the frequency of nonacid reflux episodes 
at the distal esophagus and proximal esophagus was not dif-
ferent between two groups. The possibility that nonacid reflux 
events may be important in chronic cough was highlighted by 
Irwin et al.
19 who reported improvements in chronic cough after 
laparoscopic fundoplication in patients where acid suppression 
had failed. However, most studies performed to date in patients 
with chronic cough have not found an increased number of re-
flux events compared to studies in healthy volunteers but relied 
on temporal associations between cough and reflux events to 
suggest a causal relationship.
20 And, the control group of this 
study was not the healthy controls but the subjects with sus-
pected symptoms of GERD except cough. So, this study did not 
show the difference of the frequency of nonacid reflux. 
The limitation of this study included the following; the data 
did not show the symptom index and symptom association 
probability. Most studies defined GERD using the symptom 
index or symptom association probability. Of course, it is im-
portant to evaluate whether the symptoms are caused by reflux 
or not. However, atypical GER symptoms usually persist and 
do not have a sudden onset easily recognized by the patient.
14,21 
This characteristic makes it difficult to mark a reflux event at 
a single point in time; the difficulty of assessment using the 
symptom index in patients with atypical symptoms makes the 
diagnosis of GERD with atypical symptoms more confusing 
than in cases with typical GERD. And also, we could not dem-
onstrate the strict temporal relationship between reflux events 
documented by MII/pH-monitoring and episodes of cough. Pre-
vious studies showed that 23% to 56% had a significant tempo-
ral correlation between coughing spells and reflux during MII/
pH-monitoring.
22 
In conclusion, the results of this study showed the diagnostic 
usefulness of MII/pH-monitoring in patients with suspected 
GERD. In addition, reflux episodes at the distal and proximal 
esophagus are important factors associated with chronic cough. 
Further studies based on large-scale population are needed to 
provide normal values of MII/pH-monitoring in Asian and more 
accurate assessment of a causal link between pathological GER 
and atypical symptoms should be developed. 
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